NFKB1 and colorectal carcinoma: Cooks et al. [25] reported that the dysregulation of the P53 signaling pathway might exacerbate the inflammatory response and protects the mutant cells from the clearance of the immune system by enhancing the activity of NF-kB, which promoted the carcinogenesis and progression of chronic inflammation and inflammation-associated CRC.